ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Faslodex With or Without Concomitant Arimidex Versus Exemestane Following Progression on Non-steroidal Aromatase Inhibitors (NSAI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00944918
Recruitment Status : Completed
First Posted : July 23, 2009
Last Update Posted : August 29, 2011
Sponsor:
Information provided by (Responsible Party):
AstraZeneca